 |
Nilofer Saba Azad | |
|---|---|
| Alma mater | Baylor College of Medicine |
| Scientific career | |
| Fields | Oncology |
| Institutions | Johns Hopkins University |
Nilofer Saba Azad is an American oncologist and physician-scientist specialized in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She is a professor at the Johns Hopkins School of Medicine and oversees clinical trials at the Sidney Kimmel Comprehensive Cancer Center.
Azad earned a M.D. at Baylor College of Medicine in 2001. She completed a residency in internal medicine at Baylor in 2004 and a fellowship in oncology and hematology at the National Cancer Institute (NCI) in 2008. Azad was certified in medical oncology by the American Board of Internal Medicine in 2007. [1]
Azad joined the Sidney Kimmel Comprehensive Cancer Center (SKCCC) in 2008. She is a professor of oncology at Johns Hopkins School of Medicine. At the SKCCC, Azad serves as co-director of the Developmental Therapeutics Clinical Research Program and the Cancer Genetic and Epigenetic Core Research Program. [2] Azad specializes in gastrointestinal, colorectal, cholangiocarcinoma, and pancreaticobiliary cancers. She researches the development of therapeutics and oversees clinical trials using epigenetic therapy, chemotherapy, and cancer immunotherapy. [1] She is a member of both the Epigenetics and Colon Cancer Stand Up 2 Cancer Dream Teams, serving as a Principal on the latter, and has held multiple leadership positions in national and international organizations. [2]
In September 2021, Azad was appointed by U.S. president Joe Biden to serve on the NCI National Cancer Advisory Board. [3] [2]
She speaks English and Hindustani. [1]
James Lewis Abbruzzese is the Chief of the Duke Division of Medical Oncology and associate director for Clinical Research for the Duke Cancer Institute. Previously, Abbruzzese was Chairman of the Department of Gastrointestinal Medical Oncology at the University of Texas M. D. Anderson Cancer Center where he held the M. G. and Lillie A. Johnson Chair for Cancer Treatment and Research and the Annie Laurie Howard Research Distinguished Professorship. Abbruzzese is one of the world's leaders in the clinical study and treatment of pancreatic cancer.
Yale Cancer Center (YCC) was founded in 1974 as a result of an act of Congress in 1971, which declared the nation's "war on cancer". It is one of a network of 56 Comprehensive Cancer Centers designated by the National Cancer Institute (NCI). Currently directed by Dr. Eric Winer, the Cancer Center brings together the resources of the Yale School of Medicine (YSM), Yale New Haven Hospital (YNHH), and the Yale School of Public Health (YSPH).
Professor David James Kerr CBE is a British Cancer Researcher. His primary area of research is treatment and management of colorectal cancer.
John E. Niederhuber was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
The Cancer Trials Support Unit(CTSU) is a service of the National Cancer Institute (NCI) in the United States.
Daniel Albo is an American surgeon, medical researcher, and pioneer in minimally invasive gastrointestinal surgical oncology. He has published in areas including laparoscopic colorectal surgery and surgical oncology. He is the director of surgical oncology services and the director of health services research at the Georgia Regents University Cancer Center.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University is an NCI-Designated Comprehensive Cancer Center in Baltimore, MD. It was established in 1973 and received its NCI designation that same year as one of the first designated cancer centers in the country.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Kenneth Wayne Kinzler is a professor of oncology, and director of the Ludwig Center at Johns Hopkins University at the Sidney Kimmel Comprehensive Cancer Center.
Nita Ahuja is a surgeon and the Chair of the Department of Surgery at Yale School of Medicine and Surgeon-in-Chief of Surgery at Yale New Haven Hospital. She is the first woman ever to serve as Chair of Surgery in Yale in its >200 year history. Before taking this position she was the first woman ever to be the Chief of Surgical Oncology at Johns Hopkins Hospital, Baltimore, USA. Ahuja researches in the field of epigenetics and is a passionate advocate of clinician scientist. She also served as the director of Sarcoma and peritoneal surface malignancy program. She is a surgeon-scientist and her research has been cited more than 11,000 times in scientific literature.
Luis Alberto Diaz, Jr. is the Head of the Division of Solid Tumor Oncology in Memorial Sloan Kettering’s Department of Medicine.
James Gordon Herman is an American oncologist.
Scott A. Waldman is an MD and biomedical scientist at Sidney Kimmel Medical College of Thomas Jefferson University, where he is the Samuel M.V. Hamilton Professor of Medicine, and also tenured professor and chair of the Department of Pharmacology & Experimental Therapeutics. He is author of a pharmacology textbook, and former chief editor of Clinical Pharmacology & Therapeutics. He is known for his work in atrial natriuretic factor intracellular signaling through guanylate cyclase (GC), and the relation of Guanylyl cyclase C (GC-C) to the pathogenesis of colorectal cancer. Also for his hypotheses concerning the roles of intestinal paracrine hormones in satiety, obesity and cancer risk. Waldman also holds a concurrent position as adjunct professor at the University of Delaware, School of Health Sciences.
Mary Armanios is Professor of Oncology, Genetic Medicine, Pathology and Molecular Biology, and Genetics at Johns Hopkins University School of Medicine and the Director of the Telomere Center at Johns Hopkins University. Her research focuses on the role of telomeres in disease.
Karen E. Knudsen is Chief Executive Officer of American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network. She is the first woman to hold that position in either organization.
Suzanne Louise Topalian is an American surgical oncologist. She is the Bloomberg-Kimmel Professor of Cancer Immunotherapy in the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine. In this role, she studies human anti-tumor immunity.
Maura Lianne Gillison is an American medical oncologist and molecular epidemiologist. She is credited as the first investigator to establish a connection between HPV and oral cancer.
Monica Bertagnolli is an American surgical oncologist and the 17th director of the National Institutes of Health. She previously served as the 16th director of the National Cancer Institute (NCI). Prior to her governmental positions, she worked at Brigham and Women's Hospital and Dana–Farber Cancer Institute and was the Richard E. Wilson Professor of Surgery at Harvard Medical School.
Patrick J. Loehrer is an American oncologist who is Indiana University Distinguished Professor, Joseph W. and Jackie J. Cusick Professor in Oncology, Professor of medicine, Indiana University School of Medicine; Director emeritus, Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Julie Renee Brahmer is an American thoracic oncologist. She is the co-director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University and the Marilyn Meyerhoff Professor in Thoracic Oncology.
This article incorporates text from this source, which is in the public domain : "President Biden Appoints Members to National Cancer Advisory Board". The White House. 2021-09-15. Retrieved 2021-09-22.| Authority control databases: Academics |
|---|
